These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 8927680
1. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F. Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680 [Abstract] [Full Text] [Related]
2. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study]. Fleischhacker WW, Barnas C, Stuppäck CH, Sperner-Unterweger B, Miller C, Hinterhuber H. Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332 [Abstract] [Full Text] [Related]
3. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C. Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870 [Abstract] [Full Text] [Related]
4. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial. Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R. Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193 [Abstract] [Full Text] [Related]
5. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]. Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW. Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338 [Abstract] [Full Text] [Related]
6. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol. Hwang TJ, Lin SK, Lin HN. J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520 [Abstract] [Full Text] [Related]
7. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness]. Wetzel H, von Bardeleben U, Holsboer F, Benkert O. Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336 [Abstract] [Full Text] [Related]
8. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania. Chan HY, Jou SH, Juang YY, Chang CJ, Chen JJ, Chen CH, Chiu NY. Psychiatry Clin Neurosci; 2010 Apr; 64(2):162-9. PubMed ID: 20447012 [Abstract] [Full Text] [Related]
9. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol. den Boer JA, Westenberg HG. Psychopharmacol Bull; 1990 Apr; 26(1):99-107. PubMed ID: 1973547 [Abstract] [Full Text] [Related]
10. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients]. Klieser E, Lehmann E, Tegeler J. Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333 [Abstract] [Full Text] [Related]
12. Low-dose zotepine in the maintenance treatment of schizophrenia. Fleischhacker WW, Stuppäck C, Barnas C, Unterweger B, Hinterhuber H. Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685 [Abstract] [Full Text] [Related]
13. [Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]. Müller-Spahn F, Dieterle D, Ackenheil M. Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():30-5. PubMed ID: 1683337 [Abstract] [Full Text] [Related]
16. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Sarai K, Okada M. Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680 [Abstract] [Full Text] [Related]